424
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients

, , , , &
Pages 952-960 | Received 23 Mar 2011, Accepted 17 Oct 2011, Published online: 27 Jan 2012

References

  • Rex T. (2005). Pharmaceutical considerations for patients with dysphagia. Gastroenterol Nurs, 28:143–144.
  • Kelly J, D’Cruz G, Wright D. (2009). A qualitative study of the problems surrounding medicine administration to patients with dysphagia. Dysphagia, 24:49–56.
  • Kelly J, D’Cruz G, Wright D. (2010). Patients with dysphagia: Experiences of taking medication. J Adv Nurs, 66:82–91.
  • Kelly J, Wright D. (2009). Administering medication to adult patients with dysphagia. Nurs Stand, 23:62–68.
  • Kelly J, Wright D. (2010). Administering medication to adult patients with dysphagia: Part 2. Nurs Stand, 24:61–68.
  • Strachan I, Greener M. (2005). Medication-related swallowing difficulties may be more common than we realize. Pharmacy in Practice, 15:411–414.
  • Nagarwal RC, Pandit JK. (2008). Phase transition system: Novel oral in situ gel. Curr Drug Deliv, 5:282–289.
  • Miyazaki S, Aoyama H, Kawasaki N, Kubo W, Attwood D. (1999). In situ-gelling gellan formulations as vehicles for oral drug delivery. J Control Release, 60:287–295.
  • Miyazaki S, Kawasaki N, Kubo W, Endo K, Attwood D. (2001). Comparison of in situ gelling formulations for the oral delivery of cimetidine. Int J Pharm, 220:161–168.
  • Kubo W, Miyazaki S, Attwood D. (2003). Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int J Pharm, 258:55–64.
  • Miyazaki S, Kubo W, Attwood D. (2000). Oral sustained delivery of theophylline using in situ gelation of sodium alginate. J Control Release, 67:275–280.
  • Kubo W, Konno Y, Miyazaki S, Attwood D. (2004). In situ gelling pectin formulations for oral sustained delivery of paracetamol. Drug Dev Ind Pharm, 30:593–599.
  • Kubo W, Miyazaki S, Dairaku M, Togashi M, Mikami R, Attwood D. (2004). Oral sustained delivery of ambroxol from in situ-gelling pectin formulations. Int J Pharm, 271:233–240.
  • Kubo W, Itoh K, Miyazaki S, Attwood D. (2005). Oral sustained delivery of theophylline and cimetidine from in situ gelling pectin formulations in rabbits. Drug Dev Ind Pharm, 31:819–825.
  • Miyazaki S, Kubo W, Itoh K, Konno Y, Fujiwara M, Dairaku M et al. (2005). The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol. Int J Pharm, 297:38–49.
  • Itoh K, Kubo W, Fujiwara M, Hirayama T, Miyazaki S, Dairaku M et al. (2006). The influence of variation of gastric pH on the gelation and release characteristics of in situ gelling pectin formulations. Int J Pharm, 312:37–42.
  • Itoh K, Kubo W, Fujiwara M, Watanabe H, Miyazaki S, Attwood D. (2006). The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen. Biol Pharm Bull, 29:343–347.
  • Itoh K, Hirayama T, Takahashi A, Kubo W, Miyazaki S, Dairaku M et al. (2007). In situ gelling pectin formulations for oral drug delivery at high gastric pH. Int J Pharm, 335:90–96.
  • Kawasaki N, Ohkura R, Miyazaki S, Uno Y, Sugimoto S, Attwood D. (1999). Thermally reversible xyloglucan gels as vehicles for oral drug delivery. Int J Pharm, 181:227–234.
  • Miyazaki S, Kawasaki N, Endo K, Attwood D. (2001). Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits. J Pharm Pharmacol, 53:1185–1191.
  • Miyazaki S, Endo K, Kawasaki N, Kubo W, Watanabe H, Attwood D. (2003). Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations. Drug Dev Ind Pharm, 29:113–119.
  • Itoh K, Hatakeyama T, Kimura T, Shimoyama T, Miyazaki S, D’Emanuele A et al. (2010). Effect of D-sorbitol on the thermal gelation of methylcellulose formulations for drug delivery. Chem Pharm Bull, 58:247–249.
  • Morris ER. (1995). Polysaccharide synergism—more questions than answers? In: Harding SE, Hill SE, Mitchell JR, (eds). Biopolymer Mixtures. Nottingham, UK: Nottingham University Press, pp 247–88.
  • Itoh K, Yahaba M, Takahashi A, Tsuruya R, Miyazaki S, Dairaku M et al. (2008). In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery. Int J Pharm, 356:95–101.
  • Itoh K, Tsuruya R, Shimoyama T, Watanabe H, Miyazaki S, D’Emanuele A et al. (2010). In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients. Drug Dev Ind Pharm, 36:449–455.
  • Itoh K, Hatakeyama T, Shimoyama T, Miyazaki S, D’Emanuele A, Attwood D. (2011). In situ gelling formulation based on methylcellulose/pectin system for oral-sustained drug delivery to dysphagic patients. Drug Dev Ind Pharm, 37:790–797.
  • Liang HF, Hong MH, Ho RM, Chung CK, Lin YH, Chen CH et al. (2004). Novel method using a temperature-sensitive polymer (methylcellulose) to thermally gel aqueous alginate as a pH-sensitive hydrogel. Biomacromolecules, 5:1917–1925.
  • Sohi H, Sultana Y, Khar RK. (2004). Taste masking technologies in oral pharmaceuticals: Recent developments and approaches. Drug Dev Ind Pharm, 30:429–448.
  • Levy G, Schwarz TW. (1958). The effect of certain additives on the gel point of methylcellulose. J Am Pharm Assoc Am Pharm Assoc (Baltim), 47:44–46.
  • Tønnesen HH, Karlsen J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm, 28:621–630.
  • d’Ayala GG, Malinconico M, Laurienzo P. (2008). Marine derived polysaccharides for biomedical applications: Chemical modification approaches. Molecules, 13:2069–2106.
  • Miyazaki S, Takahashi A, Itoh K, Ishitani M, Dairaku M, Togashi M et al. (2009). Preparation and evaluation of gel formulations for oral sustained delivery to dysphagic patients. Drug Dev Ind Pharm, 35:780–787.
  • Miyazaki S, Takeuchi S, Yokouchi C, Takada M. (1984). Pluronic F-127 gels as a vehicle for topical administration of anticancer agents. Chem Pharm Bull, 32:4205–4208.
  • Ameer B, Greenblatt DJ, Divoll M, Abernethy DR, Shargel L. (1981). High-performance liquid chromatographic determination of acetaminophen in plasma: Single-dose pharmacokinetic studies. J Chromatogr, 226:224–230.
  • Wood FW. (1968). Psychophysical studies on the consistency of liquid foods. In: S.C.I. Monograph No. 27. Rheology and Texture of Foodstuffs. London: Society of Chemical Industry, pp 40–49.
  • National Dysphagia Diet Task Force. (2002). National Dysphagia Diet: Standardization for Optimal Care. Chicago, IL: American Dietetic Association.
  • Fairbrother JE. (1974). Acetaminophen. In: Florey K, (ed). Analytical Profiles of Drug Substances, vol. 3. New York: Academic Press, pp 1–109.
  • Higuchi WI. (1962). Analysis of data on the medicament release from ointments. J Pharm Sci, 51:802–804.
  • Yamaoka K, Nakagawa T, Uno T. (1978). Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm, 6:547–558.
  • Goldschmiedt M, Barnett CC, Schwarz BE, Karnes WE, Redfern JS, Feldman M. (1991). Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology, 101:977–990.
  • Gidal BE. (2006). Drug absorption in the elderly: Biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Res, 68 Suppl 1:S65–S69.
  • Morihara M, Aoyagi N, Kaniwa N, Kojima S, Ogata H. (2001). Assessment of gastric acidity of Japanese subjects over the last 15 years. Biol Pharm Bull, 24:313–315.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.